US Patent 8648041 Double-acylated GLP-1 derivatives
Patent 8648041 was granted and assigned to Novo Nordisk on February, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 16, 2010
Date of Patent
February 11, 2014
Patent Application Number
12970196
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8648041 Double-acylated GLP-1 derivatives
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
